CD68 and infectious otitis media: As well, after 3 cycles of DSS treatment following intraperitoneal AOM injection, CD68–mEPRAP transgenic mice also exhibited less crypt loss, decreased infiltration of inflammatory cells with lower histological damage scores than WT mice (S10 Fig).